Illustration of the device mounted on a heart.
Illustration of the device mounted on a heart.
Source: Northwestern University/George Washington University

Transient pacemaker dissolves in body

Researchers at Northwestern and George Washington universities (GW) have developed the first-ever transient pacemaker — a wireless, battery-free, fully implantable pacing device that disappears after it’s no longer needed.

The thin, flexible, lightweight device could be used in patients who need temporary pacing after cardiac surgery or while waiting for a permanent pacemaker. All components of the pacemaker are biocompatible and naturally absorb into the body’s biofluids over the course of five to seven weeks, without needing surgical extraction.

The device wirelessly harvests energy from an external, remote antenna using near-field communication protocols — the same technology used in smartphones for electronic payments and in RFID tags. This eliminates the need for bulky batteries and rigid hardware, including wires (or leads). Not only can leads introduce infections, they also can become enveloped in scar tissue, causing further damage when removed.

The paper demonstrates the device’s efficacy across a series of large and small animal models. “Hardware placed in or near the heart creates risks for infection and other complications,” said Northwestern’s John A. Rogers, director of the Querrey Simpson Institute for Bioelectronic. “Our wireless, transient pacemakers overcome key disadvantages of traditional temporary devices by eliminating the need for percutaneous leads for surgical extraction procedures — thereby offering the potential for reduced costs and improved outcomes in patient care. This unusual type of device could represent the future of temporary pacing technology.”

Recommended article

“Sometimes patients only need pacemakers temporarily, perhaps after an open heart surgery, heart attack or drug overdose,” said Dr. Rishi Arora, professor of medicine at Feinberg and co-director of the Center for Arrhythmia Research. “After the patient’s heart is stabilized, we can remove the pacemaker. The current standard of care involves inserting a wire, which stays in place for three to seven days. These have potential to become infected or dislodged.”

“The transient electronics platform opens an entirely new chapter in medicine and biomedical research,” said Igor Efimov, professor of Biomedical Engineering at GW. “The bioresorbable materials at the foundation of this technology make it possible to create whole host of diagnostic and therapeutic transient devices for monitoring progression of diseases and therapies, delivering electrical, pharmacological, cell therapies, gene reprogramming and more."

Ditching restrictive, risky leads

Photo
Illustrated comparison of current technology versus the new transient technology.
Source: Northwestern University/George Washington University

Currently, to set up a temporary pacing after open heart surgery, surgeons must sew on temporary pacemaker electrodes on the heart muscle during surgery. These have leads that exit the front of a patient’s chest, connecting to an external pacing box that delivers a current to control the heart’s rhythm.

When the temporary pacemaker is no longer needed, physicians remove the pacemaker electrodes. Although uncommon, potential complications of implanted temporary pacemakers include infection, dislodgement, torn or damaged tissues, bleeding and blood clots.

With Northwestern and GW’s transient pacemaker, surgeons and patients can sidestep this potentially risky procedure. The fully implantable device is light and thin — 250 microns thick and weighing less than half a gram. Soft and flexible, it encapsulates electrodes that softly laminate onto the heart’s surface to deliver an electrical pulse.

“Instead of using wires that can get infected and dislodged, we can implant this leadless biocompatible pacemaker,” Arora said. “The circuitry is implanted directly on the surface of the heart, and we can activate it remotely. Over a period of weeks, this new type of pacemaker ‘dissolves’ or degrades on its own, thereby avoiding the need for physical removal of the pacemaker electrodes. This is potentially a major victory for post-operative patients.

“With further modifications, it eventually may be possible to implant such bioresorbable pacemakers through a vein in the leg or arm,” he added. “In this instance, it also may be possible to provide temporary pacing to patients who have suffered a heart attack or to patients undergoing catheter-based procedures, such as trans-catheter aortic valve replacement.”

Prioritizing patient comfort

Northwestern Medicine cardiac surgeon Dr. Duc Thinh Pham, who was not involved with the research, imagines a transient pacemaker undoubtedly would make his patients more comfortable. With current pacemakers, patients often feel discomfort for days after the leads are inserted. Then, they must limit their movements and activities in order to prevent the leads from dislodging.

“This transient pacemaker is brilliant,” said Pham, who has performed more than 2,000 cardiac surgeries throughout his career. “In addition to addressing the primary issue of occasional post-cardiac surgery patients needing temporary pacing due to blockages or arrhythmias, the device addresses the secondary issue of patient comfort, ability to move freely and rehabilitate. If successful, this device will greatly improve a patient’s post-operative course.”

Layered schematic of the device.
Layered schematic of the device.
Source: Northwestern University/George Washington University

Disappearing act

This is the second example of bioresorbable electronic medicine from the Rogers lab, which has been studying transient electronics for over a decade. In 2018, Rogers and colleagues demonstrated the world’s first bioresorbable electronic device — a biodegradable implant that speeds nerve regeneration. The team’s bioresorbable devices are completely harmless — similar to absorbable stitches. After fully degrading, the devices completely disappear through the body’s natural biological processes.

“There is clearly a need for better temporary cardiac pacemakers,” said Dr. Bradley Knight, the Chester C. and Deborah M. Cooley Distinguished Professor of Cardiology at Feinberg and coauthor of the study. “When I first learned about the bioresorbable nerve stimulator, I contacted Professor Rogers to explore the possibility of using this technology to pace the heart. He had already started working with Dr. Efimov to develop a small version of a bioresorbable pacemaker as a proof of concept. We then worked with both teams to develop a larger version of a bioresorbable, leadless, cardiac pacemaker that could be effective on a human scale. It’s a great example of what we can create at Northwestern by bridging the expertise in engineering and medicine.”

Pacemaker images

Device on Day 0 Device on Day 20 Device on Day 35

Depending on the patient, a temporary pacemaker might be needed anywhere from a couple days to several weeks. By varying the composition and thickness of the materials in the device, Rogers’ team can control the precise number of days it remains functional before dissolving. “We build these devices out of different types of safe, bioresorbable materials and in optimized architectures to ensure stable operation over a time period somewhat longer than is clinically necessary,” Rogers said. “We can tailor the devices to address a broad spectrum of relevant lifetimes. Transient technologies, in general, could someday provide therapy or treatment for a wide variety of medical conditions — serving, in a sense, as an engineering form of medicine.”

The study was published in the journal Nature Biotechnology.

Subscribe to our newsletter

Related articles

World first in 3D printed self-expandable stents

World first in 3D printed self-expandable stents

Researchers from CSIRO have made it possible to 3D print tailor-made stents, a critical biomedical device used to treat narrow or blocked arteries.

Improved safety standard for bionic devices

Improved safety standard for bionic devices

Researchers at University of Sydney have developed a new moisture test for bionic devices such pacemakers and cochlear implants.

Lab-created heart valves can grow with the recipient

Lab-created heart valves can grow with the recipient

Researchers have shown that lab-created heart valves implanted in young lambs for a year were capable of growth within the recipient.

Cardiac patch treats heart disease

Cardiac patch treats heart disease

Researchers have developed rubbery a bioelectronic implantable device that can monitor and treat heart diseases.

Tool with smart sensors advances cardiac surgery

Tool with smart sensors advances cardiac surgery

A new class of medical instruments equipped with an advanced soft electronics system could improve the diagnoses and treatments of a number of cardiac diseases and conditions.

3D printed artery monitors blockages from the inside

3D printed artery monitors blockages from the inside

Engineers are developing a 3D printed artificial blood vessel that allows doctors and patients to keep tabs on its health remotely.

Micro-LEDs and photovoltaic device power implants

Micro-LEDs and photovoltaic device power implants

Researchers have developed a method to power medical implants using an active photonic wireless system.

3D printed knee implant for arthritis sufferers

3D printed knee implant for arthritis sufferers

A groundbreaking new treatment that uses 3D printed implants and that could bring relief to tens of thousands of knee osteoarthritis sufferers has received approval to be trialled in UK patients.

Hip implant simulator for virtual surgery training

Hip implant simulator for virtual surgery training

The team of the Dynamic HIPS are working on a hip replacement simulator that will help future surgeons to practice the intervention and develop a reality-based feeling for the procedure.

Popular articles

Subscribe to Newsletter